— Know what they know.
Not Investment Advice
Also trades as: RVV.CN (CNQ) · $vol 0M

RVVTF OTC

Revive Therapeutics Ltd.
1W: +26.1% 1M: +15.4% 3M: -2.3% YTD: +128.3% 1Y: +97.2% 3Y: -38.2% 5Y: -94.5%
$0.02
+0.00 (+16.67%)
 
Weekly Expected Move ±21.6%
$0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 44 · $9.1M mcap · 405M float · 0.047% daily turnover · Short 70% of daily vol

Balance Sheet Trends

Total Assets
$205K -98.1% ▼
5Y CAGR: -52.3%
Total Liabilities
$4M +7.5% ▲
5Y CAGR: +34.5%
Shareholders Equity
-$3M -147.8% ▼
Cash & Investments
$15K -98.1% ▼
5Y CAGR: -60.3%
Total Debt
$67K +165.2% ▲
5Y CAGR: -32.2%
Net Debt
$52K +107.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$17M$4M$2M$773K$15K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$17M$4M$2M$773K$15K
Net Receivables$94K$113K$138K$13K$0
Inventory$0$0$19K$8K$0
Other Current Assets$33K$78K$50K$50K$10K
Total Current Assets$17M$4M$2M$1M$68K
Property, Plant & Equip.$2K$2K$1K$1K$828
Goodwill & Intangibles$12M$12M$12M$9M$0
Long-Term Investments$250K$250K$162K$116K$136K
Other Non-Current Assets$259K$149K$13K$0$0
Total Non-Current Assets$13M$13M$12M$9M$137K
Total Assets$30M$17M$14M$11M$205K
— Liabilities —
Accounts Payable$436K$4M$3M$3M$3M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$0$0
Total Current Liabilities$598K$4M$3M$3M$4M
Long-Term Debt$60K$60K$60K$0$67K
Other Non-Current Liab.$74K$77K$78K$80K$80K
Total Non-Current Liabilities$402K$296K$163K$80K$147K
Total Liabilities$1000K$4M$4M$3M$4M
— Equity —
Common Stock$42M$43M$46M$47M$48M
Retained Earnings-$36M-$54M-$61M-$66M-$77M
Accumulated OCI$11M$0$0$0$0
Total Stockholders Equity$29M$13M$11M$7M-$3M
Total Liabilities & Equity$30M$17M$14M$11M$205K
— Key Metrics —
Total Debt$416K$328K$220K$25K$67K
Net Debt-$16M-$4M-$2M-$748K$52K
Total Investments$250K$250K$162K$116K$136K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms